FRG-8701 | Interleukin Related interleukin-related.com

Product Name :
FRG-8701

Search keywords :
FRG8701

drugId :
null

Target Vo:
Histamine H2 receptor

Target Vo Short Name :
HRH2

Moa_Name:
Histamine H2 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ucb Japan Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Duodenal Ulcer

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Mirvetuximab Epigenetics
alpha smooth muscle ActinRabbit mAb Protocol
phospho-ERK1 + 2 (Thr183/Tyr185) Antibody: phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is an unconjugated, approximately 42/44 kDa, rabbit-derived, anti-phospho-ERK1 + 2 (Thr183/Tyr185) polyclonal antibody. phospho-ERK1 + 2 (Thr183/Tyr185) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, chicken, dog, cow, horse, rabbit, guinea pig background without labeling.

Author: Interleukin Related

Related Posts